ProKidney Corp PROK Q1 2026 Earnings Narrowed Loss and Steady Progress in Kidney Disease Therapy TCRT Q4 2023 Earnings EPS Misses Estimates as ClinicalStage Biotech Reports No Revenue Standard Motor Products SMP Q1 2026 Earnings EPS Surpasses Estimates by 678 Despite Unreported Revenue GTLB Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response LEA Q1 2026 Earnings Earnings Per Share Surpasses Estimates on Strong Operational Performance NATH Q4 2024 Earnings EPS of 096 Signals Resilient Profitability